• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

    5/16/25 4:10:00 PM ET
    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance
    Get the next $HSIC alert in real time by email

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.

    In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Health Care industry team in the Americas, who became a member of Henry Schein's Board of Directors on May 2, 2025.

    Max Lin leads the Health Care industry team within KKR, and since joining in 2005, he has overseen a number of investments in the areas of dental services and other health care providers, medical products and equipment, and health care software and information technology. Dan Daniel has over three decades of global leadership experience in industrial and health care sectors, including 14 years as Executive Vice President at Danaher, where he oversaw multiple segments and played a key role in advancing the company's culture and business system. In connection with each of their appointments, Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair; Mr. Daniel was appointed to the Compensation Committee; and each of Mr. Lin and Mr. Daniel was appointed to the Strategic Advisory Committee.

    "We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders."

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

    About KKR

    KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250516439220/en/

    Investors

    Ronald N. South

    Senior Vice President and Chief Financial Officer

    [email protected]

    (631) 843-5500



    Graham Stanley

    Vice President, Investor Relations and Strategic Financial Project Officer

    [email protected]

    (631) 843-5500



    Media

    Henry Schein

    Tim Vassilakos

    Executive Director, Global Corporate Communications

    [email protected]

    (516) 510-0926



    KKR

    Liidia Liuksila

    [email protected]

    Get the next $HSIC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HSIC
    $KKR

    CompanyDatePrice TargetRatingAnalyst
    KKR & Co. Inc.
    $KKR
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Henry Schein Inc.
    $HSIC
    7/14/2025$72.00Outperform → Neutral
    Robert W. Baird
    KKR & Co. Inc.
    $KKR
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    6/30/2025$150.00Overweight
    Piper Sandler
    KKR & Co. Inc.
    $KKR
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    KKR & Co. Inc.
    $KKR
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    3/20/2025$150.00 → $141.00Equal Weight → Overweight
    Wells Fargo
    Henry Schein Inc.
    $HSIC
    2/14/2025$80.00Equal Weight
    Wells Fargo
    More analyst ratings

    $HSIC
    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SupplyHouse Receives Strategic Investment from KKR

      MELVILLE, N.Y. and NEW YORK, July 17, 2025 /PRNewswire/ -- SupplyHouse (or, the "Company"), a leading pure-play e-commerce platform for the distribution of HVAC, plumbing, and electrical products, and KKR, a leading global investment firm, announced the formation of a strategic partnership to support the Company's long-term growth strategy. As part of the strategic partnership, funds affiliated with KKR have invested in SupplyHouse. Financial terms were not disclosed. Founded in 2004, SupplyHouse is one of the fastest-growing distributors in its category, having served over 7

      7/17/25 7:00:00 AM ET
      $KKR
      Investment Managers
      Finance
    • KKR Releases 2025 Mid-Year Global Macro Outlook

      Henry McVey: Stay the Course and ‘Make Your Own Luck' KKR, a leading global investment firm, today released its 2025 Mid-Year Global Macro Outlook by Henry McVey, CIO of KKR's Balance Sheet and Head of Global Macro and Asset Allocation (GMAA). In "Make Your Own Luck," McVey and his team explain why, despite the turbulent start to 2025 and additional expected market drawdowns, they remain positive in their outlook. They note their strong belief that attractive financial conditions, a global easing cycle, ongoing productivity gains, and lack of net issuance—coupled with compelling, powerful investment themes—will drive this cycle both further and longer than many think. And, while they ac

      7/16/25 7:00:00 AM ET
      $KKR
      Investment Managers
      Finance
    • Leadership Advisory Firm ghSMART Announces Significant Minority Investment from KKR

      ghSMART, a premier global leadership advisory firm, and KKR, a leading global investment firm, today announced that funds managed by KKR will acquire a significant minority stake in ghSMART (the "Company"). ghSMART partners with CEOs, boards, and investors to develop effective executive teams and support high-stakes leadership decisions. ghSMART's founder, partners, and employees will retain majority ownership in the business and the current management team, led by CEO Jeff McLean, will continue to lead the company in their current roles. Financial terms of the transaction were not disclosed. This investment marks a pivotal moment as ghSMART celebrates its 30-year anniversary. Founded in

      7/16/25 7:00:00 AM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Barakett Timothy R bought $4,127,319 worth of shares (35,000 units at $117.92) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Issuer)

      5/27/25 8:01:38 PM ET
      $KKR
      Investment Managers
      Finance
    • Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Issuer)

      5/8/25 7:01:53 PM ET
      $KKR
      Investment Managers
      Finance
    • Kkr Alternative Assets Llc bought $50,000,000 worth of Class I Common Stock (1,956,182 units at $25.56) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/6/24 9:02:29 PM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Kkr Alternative Assets Llc acquired $2,901,156 worth of Class I Common Stock (121,083 units at $23.96) (SEC Form 4)

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      7/2/25 4:05:44 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 4 filed by Large owner Kkr Group Partnership L.P.

      4 - KKR & Co. Inc. (0001404912) (Reporting)

      6/18/25 7:26:27 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 4 filed by Large owner Kkr Hawaii Aggregator L.P.

      4 - HENRY SCHEIN INC (0001000228) (Issuer)

      6/18/25 7:24:32 PM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KKR downgraded by Citizens JMP

      Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform

      7/14/25 8:40:54 AM ET
      $KKR
      Investment Managers
      Finance
    • Henry Schein downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Henry Schein from Outperform to Neutral and set a new price target of $72.00

      7/14/25 8:40:13 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • KKR downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00

      7/9/25 10:14:31 AM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    SEC Filings

    See more
    • SEC Form 8-K filed by Henry Schein Inc.

      8-K - HENRY SCHEIN INC (0001000228) (Filer)

      7/15/25 7:10:41 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • KKR & Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - KKR & Co. Inc. (0001404912) (Filer)

      6/23/25 5:00:48 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form 11-K filed by Henry Schein Inc.

      11-K - HENRY SCHEIN INC (0001000228) (Filer)

      6/20/25 8:01:34 AM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    $KKR
    Leadership Updates

    Live Leadership Updates

    See more
    • Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

      Mr. Bergman to Continue to Serve as Chairman of the Board Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of the year after 45 years at the Company, including more than 35 years as CEO. Mr. Bergman will continue to lead Henry Schein in his current role until his retirement and will remain as Chairman thereafter. The Board is commencing a formal search process in conjunction with a nationally recognized executive search firm and will consider internal and external candidates. "With the progress made advan

      7/15/25 7:05:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance
    • KKR Appoints Timothy R. Barakett to Board

      KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket

      3/13/25 4:30:00 PM ET
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Financials

    Live finance-specific insights

    See more
    • KKR & Co. Inc. to Announce Second Quarter 2025 Results

      KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be a

      7/14/25 4:15:00 PM ET
      $KKR
      Investment Managers
      Finance
    • Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million

      Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfront Cash and Up to €27 Million in Potential Future Milestone Payments Expected Net Proceeds to be Directed Towards Previously Announced Capital Allocation Priorities, Including Further Strengthening the Company's Balance Sheet DUBLIN, July 14, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading global provider of Consumer Self-Care Products, today announced it has signed an agreement with Kairos Bidco AB, an investment vehicle managed by KKR, a leading glo

      7/14/25 8:30:00 AM ET
      $KKR
      $PRGO
      Investment Managers
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FSK Announces Earnings Release and Conference Call Schedule for Second Quarter 2025

      PHILADELPHIA and NEW YORK, July 10, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its second quarter 2025 results after the close of trading on the New York Stock Exchange on Wednesday, August 6, 2025. FSK will host its second quarter 2025 results conference call via live webcast on Thursday, August 7, 2025 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the Investor Relations section of FSK's website at www.fskkradvisor.com under Events or through the following URL: htt

      7/10/25 4:15:00 PM ET
      $FSK
      $KKR
      Investment Managers
      Finance

    $HSIC
    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

      SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

      11/13/24 3:30:01 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

      SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

      11/12/24 3:50:17 PM ET
      $KKR
      Investment Managers
      Finance
    • SEC Form SC 13G filed by Henry Schein Inc.

      SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

      11/12/24 9:32:27 AM ET
      $HSIC
      Medical Specialities
      Health Care